Contraception
News
Taking a new obesity drug and birth control pills? Be careful
“It [the warning] was in the product insert, but clinically speaking, I don’t know if it was at the top of providers’ minds when they were...
News from the FDA/CDC
FDA approves first over-the-counter birth control pill
The product, OPill, is expected to be available early in 2024.
News
Frustration over iPLEDGE evident at FDA meeting
Dermatologists argue the iPLEDGE REMS burden is too high for providers and patients. Access problems persist with lockouts and some cite a lack of...
News
FDA Advisory panels consider easing isotretinoin requirements
The 2-day meeting is addressing what can be done to reduce burden with the iPLEDGE REMS while maintaining safety and preventing fetal exposure to...
News
Embattled iPLEDGE program: Changes ahead?
When the iPLEDGE program had transitioned to the new platform, the rollout was far from smooth.
News
Isotretinoin prescribers need better education on emergency contraception
Two-thirds of providers reported receiving no education on emergency contraception, despite relevance to isotretinoin patients.
News
IUD injury risk rises shortly after women give birth
Health care providers should make patients aware of the heightened risk and should monitor these patients more closely.
Conference Coverage
Hormonal contraceptives protective against suicide?
The main message is the “current use of hormonal contraceptives is not associated with an increased risk of attempted suicide in our population...
News
Double morning-after pill dose for women with obesity not effective
In a randomized, controlled trial, follicle rupture was not significantly different when the levonorgestrel-based contraception dose was doubled...
News
Women are not being warned that anesthetic may reduce birth pill efficacy
“Use of sugammadex is expected to rise as it becomes cheaper in the future, and ensuring that women receiving this medicine are aware it may...